Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.94 AUD | +0.63% | -2.41% | -2.33% |
Apr. 30 | Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases | MT |
Apr. 24 | Germany's Evotec Appoints Permanent CEO | MT |
Evolution of the average Target Price on EVT Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- EVT Stock
- Consensus EVT Limited